Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride in Recurrent Prostate Cancer During ADT
NCT00403000Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Dec 2004
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dutasteride in prostate cancer (PCa), sponsored by Roswell Park Comprehensive Cancer Center. Started Dec 2004; status: completed.
02
Drugs
dutasteride
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00403000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403000.